‘Every failed experiment is a chance to learn faster’

From the creator

Stanford biochemist Lingyin Li and her colleagues are studying a tumor-fighting “miracle molecule” that could one day inform therapies for cancer, as well as autoimmune, neurodegenerative, and age-related diseases. #ResearchMatters

Published 2025-06-20 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.